Release Date: 12/03/20 09:55 Summary: Announcement under ASX Operating Rule 10A.4.3 Price Sensitive: No Download Document 104.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%